{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:09:12Z","timestamp":1791486552052,"version":"4.3.4"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,17]]},"DOI":"10.18632\/oncotarget.13492","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T20:18:30Z","timestamp":1479845910000},"page":"4618-4628","source":"Crossref","is-referenced-by-count":71,"title":["Tyrosine kinase fusion genes in pediatric <i>BCR-ABL1<\/i>-like acute lymphoblastic leukemia"],"prefix":"10.18632","volume":"8","author":[{"given":"Judith M.","family":"Boer","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M.P.","family":"Steeghs","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o R.M.","family":"Marchante","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Boeree","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Beaudoin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Berna","family":"Beverloo","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands"},{"name":"Dutch Childhood Oncology Group (DCOG), The Hague, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland P.","family":"Kuiper","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Escherich","sequence":"additional","affiliation":[{"name":"German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia (COALL), Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent H.J.","family":"van der Velden","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ellen","family":"van der Schoot","sequence":"additional","affiliation":[{"name":"Sanquin Research and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester A.","family":"de Groot-Kruseman","sequence":"additional","affiliation":[{"name":"Dutch Childhood Oncology Group (DCOG), The Hague, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Pieters","sequence":"additional","affiliation":[{"name":"Dutch Childhood Oncology Group (DCOG), The Hague, The Netherlands"},{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique L.","family":"den Boer","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands"},{"name":"Dutch Childhood Oncology Group (DCOG), The Hague, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(12)70377-7","article-title":"Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study","volume":"13","author":"Arico","year":"2012","journal-title":"Lancet Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/leu.2014.30","article-title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031","volume":"28","author":"Rutledge","year":"2014","journal-title":"Leukemia"},{"key":"3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Kamps","year":"2009","journal-title":"Lancet Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Clifford","year":"2009","journal-title":"N Engl J Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL","volume":"122","author":"Horstmann","year":"2013","journal-title":"Blood"},{"key":"6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Rusch","year":"2014","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","article-title":"Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia","volume":"22","author":"Yan","year":"2012","journal-title":"Cancer Cell"},{"key":"8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MOH.0000000000000050","article-title":"Beyond Philadelphia: \u2018Ph-like\u2019 B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises","volume":"21","author":"Izraeli","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"9","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1038\/bcj.2016.28","article-title":"Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan","volume":"6","author":"Deguchi","year":"2016","journal-title":"Blood Cancer J"},{"key":"10","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2015-09-670166","article-title":"EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications","volume":"127","author":"Goulden","year":"2016","journal-title":"Blood"},{"key":"11","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3324\/haematol.2016.144345","article-title":"Characterization of leukemias with ETV6-ABL1 fusion","volume":"101","author":"Smith","year":"2016","journal-title":"Haematologica"},{"key":"12","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/sj.leu.2405033","article-title":"Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation","volume":"22","author":"Romana","year":"2008","journal-title":"Leukemia"},{"key":"13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2010.08457.x","article-title":"Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia","volume":"153","author":"Grand","year":"2011","journal-title":"Br J Haematol"},{"key":"14","first-page":"4","article-title":"Exploring genomic alteration in pediatric cancer using ProteinPaint","volume":"48","author":"Zhang","year":"2015","journal-title":"Nature Genetics"},{"key":"15","unstructured":"Steeghs, Jerchel, de Goffau-Nobel, Hoogkamer, Boer, Boeree, van de Ven, Koudijs, Cuppen, De Groot-Kruseman, Horstmann, Pieters, Den Boer. JAK2 aberrations in childhood precursor B cell acute lymphoblastic leukemia. Submitted."},{"key":"16","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.3324\/haematol.2015.124941","article-title":"BCR-ABL1-Like Cases in Pediatric Acute Lymphoblastic Leukemia: a Comparison Between DCOG\/Erasmus MC and COG\/St. Jude Signatures","volume":"100","author":"Den Boer","year":"2015","journal-title":"Haematologica"},{"key":"17","first-page":"2609","article-title":"Rapid capture targeted next generation sequencing (NGS) for detection of genomic kinase- and cytokine receptor rearrangements in B-precursor acute lymphoblastic leukemia","volume":"126","author":"Horstmann","year":"2015","journal-title":"Annual Meeting Abstracts Blood"},{"key":"18","first-page":"696","article-title":"Targeted locus amplification & next generation sequencing for the detection of recurrent and novel gene fusions for improved treatment decisions in pediatric acute lymphoblastic leukemia","volume":"126","author":"Den Boer","year":"2015","journal-title":"Annual Meeting Abstracts Blood"},{"key":"19","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2014.55.4105","article-title":"Outcomes of Children With BCR-ABL1-Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease","volume":"32","author":"Raimondi","year":"2014","journal-title":"Journal of Clinical Oncology"},{"key":"20","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1200\/JCO.2012.47.6770","article-title":"Tyrosine Kinase Inhibitor Therapy Induces Remission in a Patient With Refractory EBF1-PDGFRB-Positive Acute Lymphoblastic Leukemia","volume":"31","author":"Mullighan","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"21","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.3324\/haematol.2013.095372","article-title":"Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion","volume":"98","author":"Clappier","year":"2013","journal-title":"Haematologica"},{"key":"22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/leu.2009.258","article-title":"Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004","volume":"24","author":"Pieters","year":"2010","journal-title":"Leukemia"},{"key":"23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/leu.2009.249","article-title":"Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97","volume":"24","author":"Grp","year":"2010","journal-title":"Leukemia"},{"key":"24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/pbc.24273","article-title":"Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03","volume":"60","author":"Janka-Schaub","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"25","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2003.11.031","article-title":"Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia","volume":"21","author":"Van der Does-Van den Berg","year":"2003","journal-title":"J Clin Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/nbt.2959","article-title":"Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping","volume":"32","author":"Ylstra","year":"2014","journal-title":"Nat Biotechnol"},{"key":"27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/bioinformatics\/btm030","article-title":"CGHcall: calling aberrations for array CGH tumor profiles","volume":"23","author":"Ylstra","year":"2007","journal-title":"Bioinformatics"},{"key":"28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1471-2164-10-401","article-title":"CGHnormaliter: an iterative strategy to enhance normalization of array CGH data with imbalanced aberrations","volume":"10","author":"Heringa","year":"2009","journal-title":"BMC Genomics"},{"key":"29","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.3324\/haematol.2014.117424","article-title":"Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates","volume":"100","author":"Rijneveld","year":"2015","journal-title":"Haematologica"},{"key":"30","first-page":"22","article-title":"cmprsk: Subdistribution Analysis of Competing Risks","author":"Gray","year":"2013","journal-title":"R package version"},{"key":"31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v038.i01","article-title":"mstate: An R Package for the Analysis of Competing Risks and Multi-State Models","volume":"38","author":"Putter","year":"2011","journal-title":"J Stat Softw"},{"key":"32","unstructured":"Therneau. A Package for Survival Analysis in S. R package version. pp. 236\u201312. 2012."}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:49:23Z","timestamp":1594831763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,22]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,1,17]]}},"alternative-id":["13492","27894077"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13492","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,22]]}}}